|
Volumn 58, Issue 12, 2010, Pages 1193-1202
|
[Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTITHROMBOCYTIC AGENT;
CLEC2B PROTEIN, HUMAN;
LECTIN;
LIGAND;
MEMBRANE PROTEIN;
PDPN PROTEIN, HUMAN;
ANGIOGENESIS;
ANIMAL;
DRUG DESIGN;
HUMAN;
ISOLATION AND PURIFICATION;
LYMPHANGIOGENESIS;
METASTASIS;
MOLECULARLY TARGETED THERAPY;
MOUSE;
PHYSIOLOGY;
REVIEW;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION;
THROMBOSIS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DESIGN;
HUMANS;
LECTINS, C-TYPE;
LIGANDS;
LYMPHANGIOGENESIS;
MEMBRANE GLYCOPROTEINS;
MICE;
MOLECULAR TARGETED THERAPY;
NEOPLASM METASTASIS;
NEOVASCULARIZATION, PHYSIOLOGIC;
PLATELET ACTIVATION;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
THROMBOSIS;
|
EID: 79953134761
PISSN: 00471860
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (0)
|